CDH6 and ovarian carcinoma: So, mAbs 6.6.1 and 25.4.1 inhibited integrin activation induced by the CDH6 RGD motif, leading to the inhibition of pro‐metastatic activities and signaling pathways in both renal and ovarian cancer cells.